Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01165710 · ClinicalTrials.gov registry record
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
A clinical trial, sponsored by Janssen Scientific Affairs.
- Completed
- Registry status
- 10,179
- Enrollment target
NCT01165710 is a clinical trial that has completed, run by Janssen Scientific Affairs. The registered enrollment target is 10,179 participants.
The verdict
NCT01165710 has completed, sponsored by Janssen Scientific Affairs.
- COMPLETED
- Registry status
- 10,179 participants
- Enrollment target
Study Summary
The ORBIT-AF registry will be a multicenter, prospective outpatient disease registry to identify "real world" treatment patterns of atrial fibrillation. The registry will describe this patient population with regards to demographics, clinical factors, risk stratification, and geographic regions. In particular, attention will be focused on the utilization, effectiveness, and safety of antithrombotic therapies in the prevention of stroke. The registry is designed to identify reasons and risk factors for non-receipt of anticoagulation (AC) therapy, as well as reasons why AF patients who are prescribed AC therapy do not take them.
Interventions
- OTHER Patients with Atrial Fibrillation (AF)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,179 participants |
| Start Date | 2010-06 |
| Est. Completion | 2014-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01165710
The ClinicalTrials.gov registry entry for NCT01165710 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10,179 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Janssen Scientific Affairs, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Patients with Atrial Fibrillation (AF) is the first listed.
NCT01165710 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01165710 about?
NCT01165710 is a clinical study titled "Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)". The ORBIT-AF registry will be a multicenter, prospective outpatient disease registry to identify "real world" treatment patterns of atrial fibrillation. The registry will describe this patient population with regards to demographics, clinical factors, risk stratification, and geographic regions. In ...
What is the current status of trial NCT01165710?
This trial is currently completed. The enrollment target is 10,179 participants. The study started on 2010-06. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01165710?
The interventions under investigation include: Patients with Atrial Fibrillation (AF) (OTHER).
Who is sponsoring clinical trial NCT01165710?
This trial is sponsored by Janssen Scientific Affairs, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.